Takeda Pharmaceutical Company Limited Cash Flows From Used In Investing Activities
Takeda Pharmaceutical Company Limited (TAK) reported Cash Flows From Used In Investing Activities of -JPY 367.06 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2025-06-25
| Period end | Cash Flows From Used In Investing Activities 12 month |
|---|---|
| 2025-03-31 | -367.06B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | -463.86B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | -607.10B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | -198.13B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 393.53B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 292.12B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -2.84T JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | -93.34B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | -655.69B JPY 20-F · filed 2019-06-27 |